(Q54025722)
Statements
The levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers. (English)
1 reference
Choufani G
1 reference
Nagy N
1 reference
Saussez S
1 reference
Marchant H
1 reference
Bisschop P
1 reference
Burchert M
1 reference
Danguy A
1 reference
Louryan S
1 reference
Salmon I
1 reference
Kiss R
1 reference
Hassid S
1 reference
1 December 1999
1 reference
1 reference
86
1 reference
11
1 reference
2353-2363
1 reference
Identifiers
1 reference